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SUMMARY ∑ The aim of the study was to evaluate the safety and efficacy of endovascular treat-
ment of abdominal aorta aneurysm (AAA) with Talent stent-graft (TSG). From October 1999 to
February 2002, 18 patients (17 male and one female) aged 65-77, with AAA >5 cm in diameter, were
treated by bifurcated Talent stent grafting. In all patients, postinterventional CT was performed 24
hours after stent grafting. The sutures were removed on the seventh to ninth day after the procedure,
and the patients were released for home care. Regular spiral CT control evaluation was scheduled at
1, 3, 6, 9, 12 and 24 months after stent grafting. The mean follow up time was 11 months. Talent
stent grafting procedure was initially successful in all patients. During regular controls, the TSGs
were not occluded. In two (11%) patients, Talent stent grafting was preceded by preinterventional
embolization. In five (27%) patients, control spiral CT after stent grafting showed a small endoleak.
In these patients, systemic heparinization was interrupted and spiral CT was repeated after seven
days. Repeat spiral CT after seven days showed absence of endoleak in four of five (80%) patients. A
small endoleak in one patient disappeared spontaneously a month after TSG placement. The mean
annual reduction in aneurysmal sac diameter was 7.3 (0 to 28) mm. TSG placement is a safe and
efficient method of AAA treatment. In patients with accurately determined indication for the pro-
cedure, it is today considered a justified alternative to surgery.
Introduction
The incidence of abdominal aorta aneurysm (AAA)
generally ranges from 1.3% to 6.6%, and in high-risk
population from over 5% to 20%1-3. Since 1950, elective
surgery has been a common treatment method. This pro-
cedure, however, has a high mortality of 4% to 5% even
in the centers with great experience4. The morbidity and
mortality of the surgery increases with patient age. This,
and the fact that elderly patients often suffer from
comorbidity, has encouraged a search for less invasive
endovascular methods for the treatment of AAA. The
studies conducted during the last years have confirmed the
endovascular stent grafting to be a safe and efficient
method for AAA exclusion from circulation, particularly
in patients who are for some reason not eligible for sur-
gery5-9. Blum et al.8 report that endovascular stent-graft
placement is accompanied by numerous complications.
The most frequent complication is endoleak, i.e. flow from
the stent-graft lumen into the aneurysmal sac. Permanent
filling of the aneurysmal sac can cause aneurysm growth,
and increase in pressure could result in rupture and death7.
However, the perigraft flow could cease spontaneously. A
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persisting endoleak demands an additional intervention
in an attempt to reduce the blood inflow into the aneu-
rysm. A routine postinterventional CT is exceptionally
important for early endoleak detection and timely inter-
vention.
Talent stent graft (TSG; Medtronic World Medical
Manufacturing Corporation, Sunrise, Florida, USA) is an
endoprosthesis used in endovascular AAA treatment in
numerous centers worldwide10-12.
This article reports on our results with TSG in AAA
treatment.
Material and Methods
During a 29-month period (October 1999 - February
2002), 18 patients (17 male and one female), mean age 72
(55-77), with average AAA diameter of 6.9 (5.5-10.4) cm,
were treated with endovascular TSG. All patients were
informed on the possible advantages and disadvantages of
the endovascular treatment of aneurysm and were offered
to chose between surgery and endoluminal Talent stent
grafting. According to the classification proposed by Blum
et al.13, there were ten patients with type B (proximal neck
>15 mm, no distal neck but rather involvement of the
aortal bifurcation), six with type C (proximal neck >15
mm and involvement of one iliac artery) and two with
type D aneurysm (proximal neck >15 mm and involve-
ment of both iliac arteries). Nine risk factors were deter-
mined: nicotine consumption, arterial hypertension, dia-
betes mellitus, hyperlipidemia, coronary disease, chronic
obstructive pulmonary disease, renal insufficiency and
presence of another aneurysm. The mean number of risk
factors was 3.1 (0-6). The iliac artery diameter was 8-24
mm (mean diameter 12.4 mm). Unilateral iliac artery
aneurysm was found in six, and bilateral in two patients.
In both patients, it was possible to place stent graft so as
to exclude the aneurysm from the circulation and one of
the internal iliac arteries being left open. Bifurcated TSG
was placed in all patients. In three (17%) patients (two
with type C aneurysm and one with type D aneurysm),
additional iliac extensions were needed besides the basic
bifurcated stent graft. To prevent the occurrence of type
II endoleak, in two (11%) patients TSG placement was
preceded by embolization. In one patient, short occlusion
of the left outer iliac artery was recanalized before stent
grafting. After TSG placement, the recanalized site was
bypassed with dia. 10 mm SMART stent (Cordis,
Johnson & Johnson Medical NV/SA).
Bare-spring TSG was used in all patients. This
endoprosthesis has 15 mm of proximal stent end not cov-
ered with Dacron. Suprarenal fixing of TSG was used in
five (27.7%) patients.
The TSG body diameter varied from 24 to 32 mm,
and the iliac extension was between 10 and 16 mm in
diameter. The prosthesis length was between 160 and 170
mm. When using TSG body £28 mm, a 22F introducer
was used, and when the TSG body diameter was >28 mm,
the introducer was 24F. An 18F introducer was used for
contralateral iliac extension.
In 17 patients, TSG was done under epidural anesthe-
sia, and in only one patient under general anesthesia. The
interventions were performed in an angiosurgery theater
with Multistar TOP (Siemens).
Infrarenal localization, size of aneurysmal sac, and in-
volvement of iliac arteries were shown on preoperative an-
giography which was as a rule performed with a 5F Pigtail
Altaflow measuring catheter (Ettlingen, Germany).
Spiral CT was done prior to the intervention and 24
hours after TSG placement, and on controls performed
at 1, 3, 6, 9, 12 and 24 months after stent grafting. The
evaluation was performed on a spiral CT Somatom Emo-
tion (Siemens). Each evaluation included contrast en-
hanced and noncontrast scans. In patients with AAA, the
CT finding is the basis for decision-making on TSG
placement. At the same time, one of CT scans was used
for measurements to choose appropriate prosthesis size.
On contrast-free scanning, we used 8 mm collimation,
8 pitch, 130 kV, 120 mAs, and on contrast enhanced scan-
ning 3 mm collimation, 1.5 pitch, 130 kV, 96 mAs. In
both cases, the region from the celiac trunk to femoral
arteries was scanned. On contrast enhanced scanning, an
automatic syringe was used to administer 120 ml of
Omipaque 300 at a rate of 4 ml/s. The scanning started
28 seconds after the beginning of contrast administration.
In postprocessing, 3D reconstructions of contrast-en-
hanced examination were performed.
We retrospectively analyzed all CT scans of our 18
patients. Maximal aneurysm diameter, changes in aneu-
rysm diameter during follow-up, and existence, size and
localization of endoleak were analyzed. The endoleak was
categorized as small (£25% of AAA circumference filled
with contrast medium), moderate (>25% but £50%), or
large (>50%)14. The contrast-free scans were used to ana-
lyze aortal calcifications that sometimes mimic perigraft
flow.
In all patients, heparinization started already during
the intervention. After TSG had been placed, 10,000 IU
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of heparin were administered intra-aortally. Systemic
heparinization, which is usually achieved with 100 IU of
heparin per kilogram of body weight, was continued for
48 hours. After that the patient was given Aspirin in a
dose of 100 mg/day. In five patients in whom control CT
performed 24 hours after the intervention indicated type
I endoleak, heparin administration was stopped and As-
pirin treatment started. Antibiotic therapy with Ceftia-
xone in a dose of 1x2 g/day was started a day before the
intervention, and continued until the third postin-
terventional day. The first four patients spent 24 days in
intensive care, and were then moved to the Department
of Vascular Surgery. The sutures were removed seven to
nine days after the intervention, and the patients were
released for home care.
Results
Eighteen patients with infrarenal AAA were treated
by endovascular stent grafting. Placing of TSG was suc-
cessful in all patients (Fig. 1 a, b, c). In five (27.7%) pa-
tients, postinterventional CT performed 24 hours after
the intervention revealed perigraft flow. According to the
classification proposed by Franco et al.14, three patients
had small perigraft flow (60%) and two patients had
modest perigraft flow (40%). In three (60%) patients,
endoleak was associated with type B aneurysm, and in two
(40%) patients with type C aneurysm. In four (80%) pa-
tients, endoleak was detected at the junction of the stent
graft body sleeve and iliac extension, and in one (20%)
patient in proximal neck in contact between the stent graft
body and aortal wall. Systemic heparinization was stopped
in all patients with endoleak. Control CT was done prior
to release from the hospital. In four patients, endoleak
ceased spontaneously (Fig. 2a, b), and in one patient it was
considerably reduced. In the latter patient, the perigraft
flow was not visible on control CT done a month after
TSG placement. In patients with internal iliac artery and
lumbar arterial embolization done prior to TSG place-
ment, no endoleak was detected.
Postinterventional temperature, never in excess of 38.5
oC, was noticed in 15 (83.3%) patients. No special therapy
was needed and the temperature spontaneously normal-
ized during their stay at the hospital. Only one patient was
subfebrile for 15 days. It was the patient with endoleak
persisting on CT performed seven days after the interven-
tion. The local finding at access points was good, and
control CT showed regular position of TSG with no signs
of any surrounding reaction.
The first four patients were placed in Intensive Care
during the first postinterventional day. The mean resi-
Fig. 1. AAA, maximum diameter 74 mm, 71-year-old male: a) preinterventional angiography: infrarenal AAA with proximal neck 15
mm long and prominent angulation; b) bifurcated bare spring TSG placed; c) postinterventional angiography: aneurysm excluded from
circulation. No signs of perigraft flow.
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dence time was 21 hours. None of the patients required
any additional therapy, so we believe that their stay in
Intensive Care was not necessary.
Sutures at the sites of inguinal incisions were removed
on the seventh to ninth postinterventional day, and the
patients were released home. The mean hospitalization
time was 9.1 (7-14) days.
The mean follow-up time was 11 (3-25) months.
During the follow-up period, no TSG migration or late
endoleaks were noticed. Maximal AAA diameter ranged
between 5.5 and 10.4 cm. No increase in the aneurysmal
sac was noticed in any patient during the follow-up. As
expected, comparison of preinterventional and immedi-
ate postinterventional measurements showed no change
in AAA diameter. However, subsequent control evalua-
tions obtained between the third and twelfth postin-
terventional month showed a considerable AAA diameter
reduction. Only one patient showed no reduction in the
aneurysmal sac diameter. It should be noted that this pa-
tient did not belong to the group of patients with early
endoleak. The mean aneurysmal sac reduction was 7.3 (0-
28) mm (Fig. 3 a, b).
On control scans of the patients in whom the bare
spring TSG wires were placed across the renal artery ori-
gin, no renal stenosis was noticed, and the kidney size
remained unchanged.
Discussion
Earlier trials and numerous clinical studies point to the
success of AAA treatment with endovascular stent graft-
ing5-16. In the literature, treatment success of as much as
90%-96% of patients is quoted17. In a series of 121 pa-
tients, using different types of endoprosthesis, May et al.9
achieved a primary success rate of 88%. It was confirmed
by the studies of Blum et al.13 in a series of 154 patients,
with successfully placed bifurcated stent graft in 87% of
patients. In this series, surgical conversion was done in
three patients only, whereas serious complications includ-
ing one death occurred in 2%, and minor complications
in 8% of patients. Ivancev et al.18, and Moore et al.19 re-
port on similar results. We report on our own results with
TSG use in endovascular treatment of AAA. Our series
included 18 patients, all with successfully placed bifur-
cated TSG.
The proximal end of TSG is designed in three shapes.
In the bare spring design, 15 mm of the proximal end of
the prosthesis body, which equals the length of a segmen-
tal stent, is not covered with Dacron. The beginning of the
covered part is marked with platinum markers. To prevent
curling of the graft material, the upper edge of Dacron is
fixed with an additional wire loop. This TSG type is also
known as “free flow” because it enables unobstructed flow
Fig. 2. a) Postinterventional contrast enhanced CT in a patient with AAA 24 hours after TSG placement: visible endoleak at the junction
of the stent-graft body sleeve and opposite iliac extension. Contrast colors <25% of the cross-section surface (arrow), which is an indication
of small perigraft flow; b) control contrast enhanced CT done after seven days. No signs of endoleak.
J. MaπkoviÊ et al. 3rd Congress of Croatian Society of Radiology with International Participation
Acta clin Croat, Vol. 41, No. 1, 2002 57
through the lateral wall of the proximal part of the stent
graft. In experiments with animals, Whitbread et al.20
placed Wallstent graft across the renal artery origin and no
change in the renal flow was noticed in any animal. Con-
trary to these findings, Sapoval et al.21 describe stenoses or
occlusions of the internal iliac artery in as many as 41% of
patients whose origins were crossed over with Wallstent. In
the open web design, 15 mm of the proximal end of the
TSG body are covered with Dacron in a zigzag technique,
so that part of the stent-graft resembles a crown. The third
design is the one with the proximal end of TSG completely
covered with Dacron. The advantage of the bare spring
design is that it can be used in an aneurysm with short
proximal neck. In such patients, the Nitinol bare springs of
the stent-graft can be placed across the renal artery origin
without causing any obstruction to the blood flow. The
other two designs ensure better adhesion of endoprosthesis
to the aortal wall, but they are not to be placed across the
renal artery origins, so they can only be used in patients with
proximal neck longer than 15 mm. Armon et al.22 believe
that, because of the short AAA proximal neck, the open
web design of TSG can only be used in a smaller number
of patients. In patients with short aneurysm neck, the proxi-
mal part of TSG must be anchored above the renal artery
Fig. 3. A 54-year-old male with infrarenal aneurysm, maximum diameter 64 mm: a) postinterventional contrast enhanced CT done 24
hours after bifurcated TSG placement; no change in aneurysm diameter; b) control contrast enhanced CT done six months after TSG place-
ment. A significant reduction in the aneurysm sac diameter visible.
Fig 4. a) Deployment of bare spring TSG body with road map control. Wires of bare proximal part of the stent-graft across the renal artery
origin (arrows). Platinum marker at the beginning of Dacron cover placed downstream the renal artery origin (arrow top); b)
postinterventional angiography: aneurysm excluded from circulation. Flow through renal arteries not compromised.
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origin, thus they are only suitable for use of the bare spring
design. In our patients, we used only the bare spring TSG.
In five (27.7%) patients, its bare proximal end passed across
the renal artery origin (Fig. 4 a, b). In patients with only
one kidney, or those with intensive atherosclerotic changes
of renal arteries, TSG was always deployed downstream the
renal artery origin site.
Endoluminal placement of stent-graft was performed
by a multidisciplinary team including an interventional
radiologist, a vascular surgeon and an anesthesiologist.
There is a disagreement between different authors on where
the intervention should be performed. Some authors pre-
fer operating rooms (OR) because of the sterile conditions,
while others perform the interventions in semisterile
angiosurgery theaters because of much better fluoroscopic
images and better quality of road mapping. In our hospi-
tal, the OR and angiosurgery theater are located on the
same floor, so endovascular stent-grafting was performed
in the angiosurgery theater. The patient was washed and
prepared for the intervention as if it were a major surgery.
TSG was as a rule placed under epidural anesthesia. Gen-
eral anesthesia was used in only one patient with extensive
degenerative changes of lumbar vertebrae.
Franco et al.14 report on the endoleak incidence on ini-
tial CT in 32% of patients. The importance of perigraft flow
after endovascular stent grafting has not yet been deter-
mined. Matsumura et al.23 indicate that permanent
endoleak can cause an increase in aneurysm diameter and
intra-aneurysm pressure. For this reason, Rozenblit et al.24
underscore the value of arterial spiral CT in detecting and
follow-up of endoleak. Franco et al.14 write about a decrease
in AAA diameter in six out of seven patients with persis-
tent endoleak, and increase in aneurysm diameter in the
patients in whom endoleak was not confirmed by CT. The
spontaneous disappearance of endoleak is an indication that
patients with initially confirmed endoleak are not necessar-
ily candidates for surgery or interventional radiology.
Franco et al.14 find that any endoleak not larger than half
of the AAA circumference can heal spontaneously. Moore
and Rutherford19 report on spontaneous cease of endoleak
in 53% of patients from their series. Type I endoleak, which
is also the most frequent perigraft flow in postinterventional
CT, is a consequence of incomplete exclusion of the aneu-
rysmal sac from the circulation and can occur at different
locations14. The endoleak from the proximal part of the
stent-graft could be caused by distal migration of the stent-
graft, which is most frequently a consequence of short or
wide proximal neck of AAA. A distal endoleak occurs when
the iliac extension size is incorrectly selected or when the
graft is short. Dorffner et al.17 report that even microscopic
sutures on the stent-graft coating and incomplete adhesion
of the stent-graft to the blood vessel wall could also cause
endoleaks. In all our patients, TSG placement was success-
ful. Postinterventional CT showed the presence of endoleak
in 27.7% of patients, and it spontaneously ceased in all of
them. In four out of five patients, the endoleak occurred at
the junction of the stent-graft body sleeve and iliac exten-
sion for contralateral iliac artery, and in one patient at the
contact between the wall of the proximal neck of AAA and
the stent-graft body. It should be noted that all patients un-
derwent systemic heparinization. Postinterventional CT
that detected endoleak was performed only 24 hours after
TSG placement. Therefore, there are two possible causes
of endoleaks in our patients. Firstly, 24 hours might be too
short a period for a material with memory, such as Nitinol
from which the TSG wires are made, to adopt its final shape
and establish the desired contact. This could be supported
by the fact that the most frequent endoleak location was the
junction between the stent-graft body and iliac extension.
The endoleak can also be caused by systemic hepariniza-
tion. We stopped systemic heparinization in all patients
with endoleak. This theory is supported by the fact that
control CT performed seven days after TSG placement did
not show endoleak in four patients, while in the fifth pa-
tient it considerably subsided. Control CT obtained in the
fifth patient one month after the intervention indicated no
presence of endoleak.
Some studies report on late endoleak as a consequence
of caudal migration of the stent-graft, disconnecting of
the stent graft body from the contralateral iliac extension,
and graft rupture13,20. Similar to Uflacker et al.10 and
Hausegger et al.12, we observed no TSG migrations.
Hausegger et al.12 find this to be attributable to the stent-
graft construction. Longitudinally placed Nitinol wires
support the entire construction and prevent knicking and
longitudinal shrinking that could be caused by telescopic
retraction of the stent-graft segment. Additionally, the
iliac extensions are well fixed in iliac arteries and act as
support poles.
Another frequently mentioned reason for late endoleak
is disconnecting of the stent-graft parts. However, discon-
necting is highly improbable in TSG. When TSG elements
are correctly placed and well adhere to each other, they
cannot be separated without use of intensive force.
Endoleak can be caused by flow through arteries origi-
nating from the vessels changed by aneurysm. These are
most often lumbar arteries, lower mesenteric artery, and
internal iliac artery25,26. Such endoleak often causes an
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increase in the intra-aneurysmal pressure, so its early de-
tection is particularly important14. This endoleak type was
not found in our patients. However, preinterventional
examinations detected arteries that could cause endoleak
in two patients. In one patient, two wide lumbar arteries
originated from the AAA that sent collaterals to iliac ar-
teries. Both arteries were detected on angiography and
arterial CT. To prevent endoleak, both arteries were
embolized with microcoils. In the other patient, the right
hypogastric artery originated from aneurysmatic expan-
sion of the common iliac artery. In this patient, to bypass
AAA and right common iliac artery, an additional iliac
extension had to include the beginning of the right ex-
ternal iliac artery. In order to prevent backflow and
endoleak, we decided to perform preinterventional em-
bolization. Metal coils were used to occlude the hypogas-
tric artery origin. Cynamon et al.27 report on 41% of com-
plications after hypogastric artery embolization. We be-
lieve that embolization of one hypogastric artery at its
origin does not cause complications because such high
embolization prevents filling of aneurysm, and does not
prevent backflow into the hypogastric artery branches
located distally from the embolization site. After embo-
lization, our patient showed neither signs of claudication
nor ischemia of pelvic organs. Control examinations of
both patients that underwent preinterventional emboliza-
tion revealed no endoleak.
Mialhe et al.28 noticed that in 20% of patients, a spon-
taneously closed perigraft flow could reopen at 12-14
months. Similar observations were recorded by Parodi29,
who reports on late endoleak in 10% of spontaneously
healed perigraft flows. Our patients with endoleak were
followed up for a mean of 10.9 months (3-18) months,
and no secondary endoleaks were detected.
Small endoleaks are easily overseen on arterial CT
scans. For this reason, Golzarian et al.30 recommend that
biphasic spiral CT be used for endoleak detection. This
method detects by 11% more endoleaks than arterial CT
alone. The protocol of such examination includes native
scanning, which is very useful for differentiation of small
endoleak from calcifications in aortal wall. We used the
scanning protocol of Golzarian et al.30 in all our patients.
Parodi et al.5 were the first to present their observations
on reduced AAA diameter after endovascular stent grafting.
The stent-graft occludes lateral aortal branches, and
neointimal hyperplasia manifests on its surface. The
neointima growing along the stent-graft, the same as ad-
ventitial reaction  and mechanical effect of the stent-graft,
prevents aneurysm expansion32. Reduction in the aneurys-
mal sac diameter is expected three months after the stent-
graft placement. Blum et al.13 noticed an insignificant re-
duction in the aneurysmal sac diameter during the first 12
months, and a significant reduction 24 months after the
procedure. The filling of the aneurysm through lumbar
arteries or lower mesenteric artery has a contrary effect that
prevents reduction of aneurysm. Matsumura et al.23 noticed
that a persisting endoleak may cause an increase in the
aneurysm diameter. Increase in AAA diameter was not
recorded in any of our patients. In only one patient, the
aneurysm diameter remained unchanged 12 months after
TSG placement. In all other patients, the aneurysm diam-
eter was reduced. The most significant reduction was no-
ticed between the third and twelfth month. The mean re-
duction was 7.3 (0-28) mm. Comparison of the results of
AAA diameter reduction in patients in whom endoleak was
detected on the first postinterventional CT and those with-
out endoleak showed no significant difference in aneurys-
mal sac diameter between them. On the contrary, the most
significant reduction in diameter (28 mm) was noticed in
a patient with early perigraft flow.
Conclusion
The results obtained in our series of patients show that
TSG placing is a successful method of AAA treatment.
The results obtained are consistent with those reported in
the literature. Although endoleak was a common event,
in most cases it ceased spontaneously. TSG resulted in
reduction of AAA diameter in a large percentage of pa-
tients. The aneurysm diameter was reduced in patients
with complete primary success as well as in those with
primary endoleak that spontaneously ceased during the
follow-up. Therefore, it is concluded that endoluminal
placement of TSG is a safe and efficient method of AAA
treatment. We believe that in patients with accurately
determined indication for the procedure, it is a justified
alternative to surgery.
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Saæetak
NA©E ISKUSTVO U ENDOVASKULARNOM LIJE»ENJU ANEURIZME ABDOMINALNE
AORTE TALENT STENT-GRAFTOM
J. MaπkoviÊ, S. KopliÊ, T. Bakotin, L. Cambi-Sapunar, V. RadoniÊ, T. BatiniÊ, T. BoriÊ, D. BariÊ, Æ. GrbiÊ,
R. OpaËak, I. ©tula i I. ©tambuk
Cilj rada bio je procijeniti sigurnost i uËinkovitost endovaskularnog lijeËenja aneurizme abdominalne aorte (AAA) talent
stent-graftom (TSG). Od listopada 1999. do veljaËe 2002. godine 18 bolesnika (17 muπkaraca i jedna æena) æivotne dobi izmeu
65 i 77 godina s AAA promjera >5 cm lijeËeno je postavljanjem bifurkacijskog TSG. U svih bolesnika poslijeintervencijski CT
raen je 24 sata nakon intervencije. Sedmog do devetog poslijeintervencijskog dana skinuti su πavi i bolesnici su otpuπteni na
kuÊnu njegu. Redoviti kontrolni pregledi provedeni se spiralnim CT-om, i to 1., 3., 6., 9., 12. i 24. mjeseca nakon postavljanja
TSG. Srednje vrijeme praÊenja iznosilo je 11 mjeseci. U svih bolesnika postignut je primarni uspjeh, a na kontrolnim pregledima
TSG je bio prohodan. U dvoje (11%) bolesnika prije postavljanja TSG napravljene su prijeintervencijske embolizacije. U petoro
(27%) bolesnika na poslijeintervencijskom CT-u bilo je vidljivo manje endopropuπtanje. U tih bolesnika ukinuta je sistemska
heparinizacija i na spiralnom CT-u ponovljenom nakon sedam dana u Ëetvoro od pet (80%) bolesnika endopropuπtanja viπe nije
bilo. U jednog je bolesnika manje endopropuπtanje spontano prestalo mjesec dana nakon postavljanja TSG. Srednje smanjenje
promjera aneurizmatske vreÊe iznosilo je 7,3 mm (0-28 mm) na godinu. Postavljanje TSG predstavlja sigurnu i uËinkovitu metodu
lijeËenja AAA. U bolesnika s pravilno postavljenom indikacijom danas se opravdano smatra alternativnom metodom kirurπkom
lijeËenju.
